Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DCTN5 encodes a subunit of the dynactin complex, which is crucial for dynein-dependent microtubule transport. Dynactin is involved in various cellular processes, including intracellular trafficking and regulation of disease-related mechanisms in neurodegeneration and cancer. While DCTN5 is not typically considered a therapeutic target like receptors or enzymes, it plays a significant role in cellular processes and disease pathophysiology. Its involvement in intracellular transport and potential as a prognostic biomarker in certain cancers make it an important biological molecule for research.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynactin subunit 5 (DCTN5).